Research prototype, not medical advice.

Clonal hematopoiesis (mutations in DNMT3A, TET2, ASXL1, JAK2) affects more than 10% of people over 70 and raises the risk of blood cancer and death.

Confidence
Established
Level of evidence
Observations in humans
Observed in
Human
Mission
Map of aging (12 hallmarks)
Concepts
Chronic inflammationClonal hematopoiesis (CHIP)TET2Cancer

What the sources say

Each row is an article. “Supports”: it backs the claim. “Contradicts”: it goes against it. “Qualifies”: it limits it (another species, a weaker effect…).

DirectionSourceWhere in the articleStatus
Supports Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
Steensma et al. · Blood 2015
— Verified
Supports Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Jaiswal et al. · New England Journal of Medicine 2014
— Verified

Related claims